---
category: trading
circular_id: bf3bf3dc7ef1bf04
date: '2025-12-10'
description: 'BSE revokes the suspension of trading in equity shares of Vivimed Labs
  Ltd. (Scrip Code: 532660), allowing normal trading to resume.'
draft: false
guid: https://www.bseindia.com/markets/MarketInfo/DispNoticesNCirculars.aspx?Noticeid={619F0115-D16A-4EFB-9453-946EE60A47FC}&noticeno=20251210-26&dt=12/10/2025&icount=26&totcount=50&flag=0
impact: medium
impact_ranking: medium
importance_ranking: medium
justification: Revocation of trading suspension is significant for the affected company
  and its shareholders, allowing normal trading activity to resume
pdf_url: https://www.bseindia.com/markets/MarketInfo/DownloadAttach.aspx?id=20251210-26&attachedId=dddbf0c7-7976-48a2-a472-a5e79fb3ed2d
processing:
  attempts: 1
  content_hash: 09f5cba0c06828e2
  processed_at: '2025-12-10T13:04:14.111678'
  processor_version: '2.0'
  stage: completed
  status: published
published_date: '2025-12-10T11:05:26+00:00'
rss_url: https://www.bseindia.com/markets/MarketInfo/DispNoticesNCirculars.aspx?Noticeid={619F0115-D16A-4EFB-9453-946EE60A47FC}&noticeno=20251210-26&dt=12/10/2025&icount=26&totcount=50&flag=0
severity: medium
source: bse
stocks:
- VIVIMED
tags:
- equity
- release
- trading-resumption
- vivimed-labs
title: Revocation of Suspension in Trading of Equity Shares of Vivimed Labs Ltd.
---

## Summary

BSE has issued a circular revoking the suspension of trading in equity shares of Vivimed Labs Ltd. (Scrip Code: 532660). This action lifts the previously imposed trading restrictions, permitting normal trading operations to resume for the company's shares on the exchange.

## Key Points

- Trading suspension for Vivimed Labs Ltd. equity shares has been revoked
- Scrip Code: 532660
- Normal trading activities can now resume
- The revocation indicates the company has likely fulfilled compliance requirements or resolved issues that led to the original suspension

## Regulatory Changes

The suspension status has been changed from suspended to active, restoring normal trading capabilities for Vivimed Labs Ltd. equity shares.

## Compliance Requirements

No specific compliance requirements are mentioned for market participants. The company has presumably met the necessary conditions for revocation of the suspension.

## Important Dates

- Circular Date: December 10, 2025
- Effective Date: As per the circular issuance

## Impact Assessment

This revocation has a positive impact on:
- **Investors**: Shareholders can now trade shares freely without restrictions
- **Company**: Vivimed Labs Ltd. regains normal market status and liquidity
- **Market**: Restores confidence in the company's compliance status
- **Liquidity**: Normal trading volumes and price discovery mechanisms can resume